It's shorthand for the dietary approach that works best alongside GLP-1 receptor agonist medications like Compounded Semaglutide and Compounded Tirzepatide
However, because tirzepatide can cause nausea, vomiting, or constipation in some patients, these side effects may theoretically trigger diverticulitis symptoms in susceptible individuals
Furthermore, the consistent reduction in the risk of MACEs and MAKEs observed with GLP-1 RAs use across patient subgroups underscores the potential of these agents in managing cardiorenal risk
In addition, office-based measurements of systolic and diastolic blood pressure (BP) were reduced with tirzepatide, but heart rate (HR) was increased, consistent with known effects of GLP-1 agonists
These typically resolve within 24 to 48 hours
A very gradual schedule allows the person and their treatment team to monitor the psychological response to reduced appetite alongside the physical effects